Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothMarc A. Pfeffer, Robert M. Califf, John J.V. McMurray et al.|New England Journal of Medicine|2003Cited by 2.5k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial InfarctionNagesh S. Anavekar, Marc A. Pfeffer, Lars Køber et al.|New England Journal of Medicine|2004Cited by 1.9k
Myocardial Viability and Survival in Ischemic Left Ventricular DysfunctionRobert O. Bonow, Julio A. Panza, Gerald Maurer et al.|New England Journal of Medicine|2011Cited by 877
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialGeorge L. Bakris, Michael A. Weber, Pantelis Sarafidis et al.|The Lancet|2010Cited by 518
Navigating the Crossroads of Coronary Artery Disease and Heart FailureMihai Gheorghiade, Robert O. Bonow, George Sopko et al.|Circulation|2006Cited by 405